Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis

William W. Ellis, Alan N. Baer, Rose Marie Robertson, Theodore Pincus, Marvin W. Kronenberg

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


Raynaud's phenomenon and cardiac abnormalities are frequent in patients with systemic sclerosis. Radionuclide ventriculograms were obtained in 16 patients with Raynaud's phenomenon and systemic sclerosis or the related CREST syndrome and in 11 normal volunteers in order to evaluate changes in left ventricular function that might be induced by exposure to cold. Left ventricular regional wall motion abnormalities developed in nine of 16 patients during cooling compared with only one of 11 control subjects, despite a comparable rise in mean arterial pressure (p <0.02). The abnormalities occurred in seven of 11 patients with systemic sclerosis, one of four with CREST syndrome, and one with Raynaud's disease. To test the potential protective effect of nifedipine, radionuclide ventriculograms were then obtained during cooling after sublingual nifedipine (20 mg). Only five of 13 patients had wall motion abnormalities, and the severity of the abnormalities was significantly less than during the first cooling period (p = 0.03). Five of eight patients who had cold-induced wall motion abnormalities during the first cooling period had none after nifedipine, whereas two other patients demonstrated small abnormalities only during the second cooling period after treatment with nifedipine. It is concluded that cold induces segmental myocardial dysfunction in patients with systemic sclerosis and that nifedipine may blunt the severity of this abnormal response.

Original languageEnglish (US)
Pages (from-to)385-392
Number of pages8
JournalThe American journal of medicine
Issue number3
StatePublished - Mar 1986
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis'. Together they form a unique fingerprint.

Cite this